IGF::OT::IGF STABILITY STUDY OF METHOTREXATE AND PLACEBO CAPSULES
Sri International, Menlo Park CA
Investigators
Abstract
The Division of Acquired Immunodeficiency Syndromes (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), maintains a portfolio of contracts to support the development of (1) therapies for HIV infection and its complications and coinfections, and (2) microbicides for preventing the sexual transmission of HIV. Services provided under this contracts assist investigators in academic settings and small pharmaceutical firms in filling specific gaps in their drug development plan as they advance their product towards clinical investigation. The goal of the program is to conduct studies to support the development of formulations of potential therapeutic agents and microbicides. Targeted formulations shall include tablets, capsules, lyophilized powders.,
View original record on NIH RePORTER →